Concurrent Investment Advisors LLC lifted its position in shares of Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS by 454.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,382 shares of the technology company's stock after acquiring an additional 6,051 shares during the quarter. Concurrent Investment Advisors LLC's holdings in Celestica were worth $2,182,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in CLS. MassMutual Private Wealth & Trust FSB raised its position in shares of Celestica by 42.5% during the third quarter. MassMutual Private Wealth & Trust FSB now owns 124 shares of the technology company's stock worth $31,000 after acquiring an additional 37 shares during the last quarter. First Horizon Corp bought a new stake in shares of Celestica during the third quarter worth $31,000. Atlantic Edge Private Wealth Management LLC bought a new stake in shares of Celestica during the fourth quarter worth $38,000. Avion Wealth bought a new stake in shares of Celestica during the third quarter worth $40,000. Finally, Fifth Third Bancorp raised its position in shares of Celestica by 48.7% during the third quarter. Fifth Third Bancorp now owns 171 shares of the technology company's stock worth $42,000 after acquiring an additional 56 shares during the last quarter. Institutional investors own 67.38% of the company's stock.
Analyst Ratings Changes
A number of research firms have recently weighed in on CLS. Wolfe Research upgraded Celestica to a "strong-buy" rating in a research report on Tuesday, February 17th. Citigroup dropped their price objective on Celestica from $375.00 to $338.00 and set a "buy" rating for the company in a report on Friday, January 30th. Canaccord Genuity Group upped their price objective on Celestica from $400.00 to $430.00 and gave the company a "buy" rating in a report on Monday, February 2nd. Canadian Imperial Bank of Commerce upped their price objective on Celestica from $360.00 to $425.00 and gave the company an "outperformer" rating in a report on Tuesday, April 14th. Finally, JPMorgan Chase & Co. upped their price objective on Celestica from $360.00 to $410.00 and gave the company an "overweight" rating in a report on Thursday, April 16th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat, Celestica currently has a consensus rating of "Moderate Buy" and a consensus price target of $393.28.
Get Our Latest Analysis on Celestica
Celestica Stock Performance
Shares of NYSE CLS opened at $361.59 on Wednesday. The stock has a 50 day moving average price of $309.83 and a 200 day moving average price of $307.90. Celestica, Inc. has a 52 week low of $81.88 and a 52 week high of $423.25. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.88 and a current ratio of 1.44. The stock has a market capitalization of $41.57 billion, a PE ratio of 43.72, a price-to-earnings-growth ratio of 1.26 and a beta of 1.88.
Celestica (NYSE:CLS - Get Free Report) TSE: CLS last issued its quarterly earnings results on Monday, April 27th. The technology company reported $2.16 EPS for the quarter, beating the consensus estimate of $2.08 by $0.08. Celestica had a return on equity of 37.35% and a net margin of 6.95%.The firm had revenue of $3.96 billion during the quarter, compared to analysts' expectations of $4.06 billion. During the same period in the prior year, the firm posted $1.20 earnings per share. The business's quarterly revenue was up 52.8% compared to the same quarter last year. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. Analysts predict that Celestica, Inc. will post 8.5 earnings per share for the current fiscal year.
Insider Transactions at Celestica
In other news, President Todd C. Cooper sold 89,484 shares of the stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $287.45, for a total transaction of $25,722,175.80. Following the transaction, the president owned 108,970 shares in the company, valued at approximately $31,323,426.50. This trade represents a 45.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Jason Phillips sold 100,000 shares of the stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $308.92, for a total value of $30,892,000.00. Following the transaction, the president owned 12,584 shares in the company, valued at approximately $3,887,449.28. This trade represents a 88.82% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 297,923 shares of company stock worth $88,027,459. Company insiders own 1.10% of the company's stock.
More Celestica News
Here are the key news stories impacting Celestica this week:
- Positive Sentiment: Q1 performance and upgraded full‑year outlook: Revenue grew ~53% YoY, adjusted EPS topped management guidance, and management raised FY2026 revenue to $19.0B and adj. EPS to $10.15 — confirming strong demand from cloud/AI customers. GlobeNewswire Q1 Release
- Positive Sentiment: Cloud, AI and CCS momentum: Management and analysts point to outsized growth from data‑center capex and CCS (cloud and hyperscaler) demand — Zacks highlights a 76% jump in CCS revenue and margin expansion as drivers of the beat. Zacks: CCS Demand
- Neutral Sentiment: Mixed headline metrics: Some reports stress a “double‑beat” (adjusted metrics) while others note revenue/EPS versus some consensus figures were softer — check the earnings transcript/notes to reconcile GAAP vs adjusted figures. Earnings Transcript
- Negative Sentiment: Profit‑taking and momentum fatigue: After the upbeat print and big guidance lift, the stock gapped down as some investors locked in gains and traders debated whether near‑term momentum had run ahead of fundamentals. Blockonomi: What Happened
- Negative Sentiment: Valuation and expectations risk: Analysts note CLS trades at a premium P/E vs. ODM peers and sector medians — rising expectations for multi‑year AI buildouts may already be priced in, increasing sensitivity to any execution slips. Seeking Alpha: Valuation & Momentum
- Negative Sentiment: Analyst/investor disappointment and high intraday volume: Multiple outlets report investors “wanted more” despite the beat — heightened volatility and heavy trading followed the print. Benzinga: Market Reaction MSN: Investors Wanted More
Celestica Company Profile
(
Free Report)
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company's service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Further Reading
Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report